Remove 2024 Remove Clinical Practice Remove Government Remove Specialization
article thumbnail

Gastroenterology Board Meeting Summary | Spring 2025

ABIM

The Specialty Board discussed the LKA in greater detail, as well as the use of artificial intelligence (AI) in assessment development and the integration of public members in ABIM Governance. Community Practice in ABIM Governance* Erica N. The LKA is not available in transplant hepatology.)

article thumbnail

Medical Oncology Board Meeting Summary | Spring 2025

ABIM

Special Announcement The Medical Oncology Board is seeking a physician practicing in a non-university/community setting to join for a three-year term starting July 1, 2026. Community Practice in ABIM Governance* Erica N. Visit the ABIM Blog for reports of prior meetings. Applications are due July 20, 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nephrology Board Meeting Summary | Spring 2025

ABIM

Lieske, MD , raised concerns about how new government policies may affect international medical graduates and health equity work at ABIM. In 2024, 77% of ABIM Board Certified nephrologists due for an assessment opted for the LKA over the traditional, 10-year MOC exam. Community Practice in ABIM Governance* Erica N.

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

See the discussion on the Special Consideration IMG (International Medical Graduates) Pilot Pathway below.) In 2024, 77% of eligible ABIM Board Certified endocrinologists who chose an assessment opted for the LKA over the traditional, 10-year MOC exam. Community Practice in ABIM Governance* Erica N.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

In 2024, 75% of infectious disease physicians who chose an assessment opted for the LKA over the traditional, 10-year MOC exam. Some members of the Specialty Board were interested in the LKA experience, participant survey results—particularly responses about fairness—and how LKA performance data might reflect on clinical outcomes.